Select Medical Holdings Corporation (SEM)
NYSE: SEM · IEX Real-Time Price · USD
27.41
+0.02 (0.07%)
Apr 26, 2024, 1:04 PM EDT - Market open
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for SEM stock have an average target of 33.75, with a low estimate of 26 and a high estimate of 39. The average target predicts an increase of 23.13% from the current stock price of 27.41.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SEM stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +42.28% | Apr 12, 2024 |
| UBS | UBS | Hold Initiates $26 | Hold | Initiates | $26 | -5.14% | Nov 30, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +42.28% | Nov 8, 2023 |
| Credit Suisse | Credit Suisse | Hold Maintains $29 → $32 | Hold | Maintains | $29 → $32 | +16.75% | Aug 7, 2023 |
| RBC Capital | RBC Capital | Buy Reiterates $38 | Buy | Reiterates | $38 | +38.64% | Jul 20, 2023 |
Financial Forecast
Revenue This Year
7.04B
from 6.66B
Increased by 5.60%
Revenue Next Year
7.36B
from 7.04B
Increased by 4.59%
EPS This Year
2.06
from 1.91
Increased by 7.61%
EPS Next Year
2.11
from 2.06
Increased by 2.70%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 7.4B | 7.7B | 8.0B |
| Avg | 7.0B | 7.4B | 7.7B |
| Low | 6.8B | 7.1B | 7.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.3% | 9.6% | 9.3% |
| Avg | 5.6% | 4.6% | 4.6% |
| Low | 1.4% | 0.9% | 0.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.16 | 2.31 | 2.46 |
| Avg | 2.06 | 2.11 | 2.36 |
| Low | 1.98 | 1.89 | 2.29 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 13.2% | 12.4% | 16.4% |
| Avg | 7.6% | 2.7% | 12.0% |
| Low | 3.6% | -8.0% | 8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.